Providing subsidized predischarge medications lowered 30-day readmission rates for populations with no comorbidities or a high burden of disease compared to unsubsidized delivery (P<0.05).
Cohort
No
Does a predischarge medication delivery program with subsidized medications reduce 30-day readmission rates compared to unsubsidized medications in patients discharged from a hospitalist service?
A predischarge medication delivery program that subsidizes prescription costs reduces 30-day readmissions more effectively and at a lower cost per readmission reduction than delivery alone in select patient populations.
p-value: p=< 0.05
OBJECTIVES: Medication nonadherence caused by difficulty obtaining and paying for medicines can increase hospital readmissions. This project implemented Medications to Beds ("Meds to Beds," M2B), a multidisciplinary predischarge medication delivery program, at a large urban academic hospital that provided subsidized medications for uninsured and underinsured patients to reduce readmissions. METHODS: This 1-year retrospective analysis of patients discharged from the hospitalist service after implementing M2B contained two groups: one with subsidized medications (M2B-S) and one with unsubsidized medications (M2B-U). Primary analysis was 30-day readmission rates for patients, stratified by Charlson Comorbidity indexes (CCIs) of 0, 1-3, ≥4 to represent low, medium, and high comorbidity burden. Secondary analysis included readmission rates by Medicare Hospital Readmission Reduction Program diagnoses. RESULTS: < 0.05). Secondary analyses found no significant differences in readmission rates when patients were stratified by Medicare Hospital Readmission Reduction Program diagnosis. Cost analyses demonstrated that subsidizing medicines cost less per patient for every 1% readmission reduction than delivery alone. CONCLUSIONS: Providing medicine to patients predischarge tends to lower readmission rates for populations with no comorbidities or with a high burden of disease. This effect is amplified when prescription costs are subsidized.
Stedge et al. (Wed,) conducted a cohort in Hospital discharge. Meds to Beds with subsidized medications (M2B-S) vs. Meds to Beds with unsubsidized medications (M2B-U) was evaluated on 30-day readmission rates (p=< 0.05). Providing subsidized predischarge medications lowered 30-day readmission rates for populations with no comorbidities or a high burden of disease compared to unsubsidized delivery (P<0.05).